Venture Capital

Elens articulates $21.6m
Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.
BurnAlong stretches $1.3m seed round
JHU-backed fitness platform operator BurnAlong obtained the cash from investors including Brown Advisory to take its total to $4.7m.
Perkii quenches $2.2m thirst
Uniseed has upped its investment in probiotic drink maker Perkii after leading the Queensland spinout’s first $3m round in 2016.
Quralis queues up $5.5m
Harvard’s Quralis has added funding from investors including Viva Biotech to take its seed total to $5.5m as it looks to advance treatments for amyotrophic lateral sclerosis to the clinic.
Understory forecasts $7.5m
4490 Ventures has returned for the latest round for weather analytics service Understory, which has disclosed a total of $24.6m in funding to date.
Qwick finds hospitality in seed round
Hospitality shift work platform Qwick’s seed investors include UAVenture Capital Fund, an independent vehicle set up to cultivate University of Arizona’s ecosystem.
Aim3D models $1.6m
Rostock-founded 3D printer maker Aim3D has secured money from investors including Brose ahead of the launch of its first product in spring 2019.
Synthorx to synthesise $100m IPO
Synthorx, spun out of Scripps Research Institute, is targeting $100m in a proposed offering half a year after it raised $63m in a series C round backed by Osage University Partners.

Other News

Marinomed makes its way to stock exchange
The biopharmaceutical spinout of University of Veterinary Medicine Vienna is issuing 400,000 shares in an initial public offering that is set to fetch between $34m and $41m.
Frontier IP gathers $3.2m
Frontier IP sold $3.2m through a placement to new and existing backers as it announced its portfolio value had risen 34% year-on-year.
ACSL approaches flotation
Utec-backed Chiba spinout Autonomous Control Systems Laboratory has filed for an initial public offering on the Tokyo Stock Exchange and plans to list on December 21.
RoadBotics inspects $3.9m
The seed funding will support CMU spinout RoadBotics’ automated road inspection platform already used by 78 clients in the US and Australia.
Exscientia scents Kinetic for acquisition
Dundee spinout Kinetic Discovery has been picked up by its peer Exscientia in a deal consolidating the equity of Frontier IP, which held stakes in both drug discovery companies.
Camel-IDS calls in $42m
Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

Editor's Picks

Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
test reg

Login